Health Catalyst, Inc.
HCAT
$2.99
$0.072.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.95% | -203.18% | -15.33% | 31.80% | 33.16% |
| Total Depreciation and Amortization | 25.81% | 15.88% | 15.94% | -5.34% | -7.50% |
| Total Amortization of Deferred Charges | 5.18% | 44.81% | 47.82% | 48.37% | 54.12% |
| Total Other Non-Cash Items | 82.74% | 240.10% | -44.32% | -26.74% | -41.54% |
| Change in Net Operating Assets | -298.81% | -156.53% | -55.13% | 71.42% | 7.57% |
| Cash from Operations | -107.47% | -658.13% | -97.27% | 81.48% | 99.29% |
| Capital Expenditure | 63.83% | 179.31% | -222.12% | -61.96% | -373.15% |
| Sale of Property, Plant, and Equipment | 100.00% | 350.00% | 133.33% | -70.00% | -70.00% |
| Cash Acquisitions | 100.00% | 100.04% | -- | -122.86% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -120.42% | -405.80% | 64.57% | -309.25% | 280.34% |
| Cash from Investing | -222.33% | -2,829.05% | 15.21% | -476.87% | 130.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -65.79% | -- | -- | -- | -- |
| Issuance of Common Stock | -20.18% | -55.87% | -19.47% | -11.39% | -35.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.48% | -33,065.47% | -646.00% | 9,441.77% | 10,716.83% |
| Foreign Exchange rate Adjustments | -163.86% | 3,350.00% | 63.16% | -382.35% | 653.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.23% | -55,577.33% | -2.91% | -795.99% | 710.25% |